Side-by-side financials for CRMD and JNJ. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRMD | JNJ |
|---|---|---|
| Market cap | - | $579.83 B |
| US-listed rank | - | #20 |
| Revenue (latest FY) | $311.71M | $94.19B |
| Net income (latest FY) | $163.06M | $26.80B |
| Net margin | 52.3% | 28.5% |
| P/E (trailing FY) | - | 21.6 |
| SEC filings | 1,001 | 984 |
In their latest fiscal years, CorMedix Inc. reported $311.71M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: CorMedix Inc. and JOHNSON & JOHNSON, or browse the full rankings.